Cargando…
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321883/ https://www.ncbi.nlm.nih.gov/pubmed/34144046 http://dx.doi.org/10.1053/j.gastro.2021.06.016 |
| _version_ | 1783730930168365056 |
|---|---|
| author | Kappelman, Michael D. Weaver, Kimberly N. Boccieri, Margie Firestine, Ann Zhang, Xian Long, Millie D. |
| author_facet | Kappelman, Michael D. Weaver, Kimberly N. Boccieri, Margie Firestine, Ann Zhang, Xian Long, Millie D. |
| author_sort | Kappelman, Michael D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8321883 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83218832021-07-30 Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease Kappelman, Michael D. Weaver, Kimberly N. Boccieri, Margie Firestine, Ann Zhang, Xian Long, Millie D. Gastroenterology Brief Communication by the AGA Institute 2021-10 2021-06-15 /pmc/articles/PMC8321883/ /pubmed/34144046 http://dx.doi.org/10.1053/j.gastro.2021.06.016 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Brief Communication Kappelman, Michael D. Weaver, Kimberly N. Boccieri, Margie Firestine, Ann Zhang, Xian Long, Millie D. Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title | Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title_full | Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title_fullStr | Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title_full_unstemmed | Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title_short | Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease |
| title_sort | humoral immune response to messenger rna covid-19 vaccines among patients with inflammatory bowel disease |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321883/ https://www.ncbi.nlm.nih.gov/pubmed/34144046 http://dx.doi.org/10.1053/j.gastro.2021.06.016 |
| work_keys_str_mv | AT kappelmanmichaeld humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT weaverkimberlyn humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT boccierimargie humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT firestineann humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT zhangxian humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT longmillied humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease AT humoralimmuneresponsetomessengerrnacovid19vaccinesamongpatientswithinflammatoryboweldisease |